- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
Capabilities
The New Administration: Enforcement and Legislative Impact
The new Biden administration and a post-pandemic world on the horizon present a landscape of evolving policy, legislative reform, and regulatory and criminal enforcement priorities. Our Task Force is drawing on first-hand prior senior government and Capitol Hill experience to help our clients across industries navigate this new world.
King & Spalding’s Government Matters Practice is uniquely positioned to help clients as the new administration’s rapidly unfolding priorities impact their business operations. We offer strategic guidance across all things government-facing, including handling complex agency interactions, developing and implementing strategies involving Congress and the Executive Branch, navigating challenging investigations and litigation, and protecting and advancing client interests.
We have decades of experience with regulatory and criminal enforcement investigations by the DOJ, SEC, CFTC, FDA, HHS, EPA, FTC, DOD, USTR, Commerce, Customs, OFAC and CFIUS. We have a deep bench of lawyers who have served in administrations of both parties, and we leverage our bipartisan relationships to optimize results in Washington, and at the state and local levels. With a global cross-disciplinary platform, we bring the right experience and relationships to bear and provide quick, integrated and seamless solutions to complex government-related challenges.
This page is intended as a resource to allow our clients to understand and monitor key issues and developments regarding the new administration and the evolving pandemic environment.
Related Lawyers
Insights
Client Alert
June 4, 2021
Executive Order on Increasing the Minimum Wage for Federal Contractors
Client Alert
May 18, 2021
The Anti-Money Laundering Act and Crypto Collide: Non-Fungible Tokens
Client Alert
April 26, 2021
Environmental Justice Rises to the Forefront of EPA Policy
News
In the News · Source: Bloomberg Law
In the News · Source: Law360
March 30, 2021
Steve Orava addresses energy trade issues facing the Biden Administration